This Author published in this journals
All Journal Biomedika
M. Arisetya Ardana
Universitas Muhammadiyah Surabaya, Surabaya

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

EFFECT OF DRUG-RESISTANT TUBERCULOSIS TREATMENT ON HEMOGLOBIN AND HEMATOCRIT LEVELS IN PATIENTS AT IBNU SINA HOSPITAL GRESIK M. Arisetya Ardana; Afrita Amalia Laitupa; Sri Widyaningsih; Eka Ari Puspita; Amelia Tantri Anggraeni
Biomedika Vol 18, No 2 (2026): Biomedika August 2026
Publisher : Universitas Muhammadiyah Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23917/biomedika.v18i2.17388

Abstract

This study aimed to analyze the effect of anti-tuberculosis drugs (OAT) on hemoglobin and hematocrit levels in patients with drug-resistant tuberculosis (DR-TB) who received treatment at Ibnu Sina Regional General Hospital, Gresik Regency, with data collected from patients undergoing treatment between 2022 and 2025. The background of this study is based on the high incidence of DR-TB cases in Indonesia and the limited number of studies focusing on this specific topic. The method used in this study was a retrospective cohort design. A total of 69 subjects were included using a total sampling technique. Data were collected from medical records and analyzed using ANOVA and Friedman tests with a significance level of p < 0.05. The results showed that there was a significant effect of DR-TB anti-tuberculosis drug treatment on hemoglobin and hematocrit levels. However, in the 6-month treatment regimen (BPaL or BPaL/M), no significant effect was observed. In conclusion, anti-tuberculosis drugs for DR-TB have a significant effect on hemoglobin and hematocrit levels in patients undergoing treatment at Ibnu Sina Regional General Hospital, Gresik Regency. This study is expected to contribute to clinical practice and serve as a basis for future research.